BioLizard
Timeline
22 events since 2018Board
Capital
Filings
Financial
Establishments
Address
20182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBfull format · 28 days before the deadline
Registered office moved within GhentNew registered office: Foreestelaan 88 Bus 201, 9000 Gent · Previous registered office: Ottergemsesteenweg-Zuid 808 bus B511, 9000 Gent · Permanent representative: Vandenberghe Sander · General meeting of 25-02-20263 points ▸
- General meeting, 25-02-2026
- Registered-office move, Foreestelaan 88 Bus 201, 9000 Gent
- Permanent representative, Vandenberghe Sander
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0713914951
Annual accounts 2024 filed PDFabbreviated format · 29 days before the deadline
2024
1 director appointed, 1 resignationResignation: Noromid VOF · Permanent representatives: Gerben Menschaert, Caroline Vanovermeire and Liesbeth Ceelen · Appointment: Effra Consult Ltd5 points ▸
- Director resignation, Noromid VOF
- Permanent representative, Gerben Menschaert
- Director appointment, Effra Consult Ltd
- Permanent representative, Caroline Vanovermeire
- Permanent representative, Liesbeth Ceelen
- The deed holds 2 more points.
Annual accounts 2023 filed PDFabbreviated format · 9 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 27 days before the deadline
Appointment: Ceelen Consultancy CommV (persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo)Permanent representative: Liesbeth Ceelen3 points ▸
- Director appointment, Ceelen Consultancy CommV (persoon belast met het dagelijks bestuur,genaamd chief executive officer ofwel ceo)
- Permanent representative, Liesbeth Ceelen
- Power of attorney, Ceelen Consultancy CommV (CEO)
- The deed holds 1 more point.
2022
Highest result from 2019 to 2025 net €597,361 ▲39.1% The operating result of €656,926 and the net result of €597,361 are both a record.
Equity above €2m equity €2.0m ▲123% After 3 profitable years in a row, equity reaches €2.0m.
Annual accounts 2021 filed PDFabbreviated format · 34 days before the deadline
2021
Equity above €500,000 equity €908,336 ▲168% After 2 profitable years in a row, equity reaches €908,336.
Annual accounts 2020 filed PDFabbreviated format · 8 days before the deadline
Publication in the Belgian Official Gazette PDFCapital €466,664, annual accounts 2021
2020
Back to profit net €57,716 The net result is €57,716, after one loss-making year.
Equity above €200,000 equity €338,525 Equity rises from -€42,224 to €338,525.
Capital increase of €266,664 to €466,664Capital from €200,000 to €466,664, 800 new shares · 744 shares · 32 shares1 point ▸
- Capital increase, €266,664
- The deed holds 8 more points.
Annual accounts 2019 filed PDFabbreviated format · 23 days before the deadline
2019
Registered office moved to GhentNew registered office: Ottergemsesteenweg-Zuid 808 bus B511, 9000 Gent · Resignation: Gerben MENSCHAERT (director) · Appointment: NOROMID VOF (director) · General meeting of 10-04-20196 points ▸
- General meeting, 10-04-2019
- Director resignation, Gerben MENSCHAERT
- Director appointment, NOROMID VOF
- Permanent representative, Gerben MENSCHAERT
- Board meeting, 10-04-2019
- Registered-office move, Ottergemsesteenweg-Zuid 808 bus B511, 9000 Gent
Permanent representative: VAN dEN BERGHE Jan Magdalena Marcel3 points ▸
- Board composition, NOVALIS GENERAL PARTNERS (director)
- Permanent representative, VAN dEN BERGHE Jan Magdalena Marcel
- Board composition, MENSCHAERT Gerben Clement Angèle (director)
- The deed holds 1 more point.
2018
IncorporationFounders: NOVALIS and MENSCHAERT Gerben Clement Angèle · Founding capital of €200,000, 1,000 shares, €62,000 paid up · Appointments: NOVALIS (managing director and chair of the board) and MENSCHAERT Gerben Clement Angèle (director) · published on 28-11-20187 points ▸
- Founder, NOVALIS
- Founder, MENSCHAERT Gerben Clement Angèle
- Founding capital, €200,000, 1,000 shares
- Director appointment, NOVALIS
- Director appointment, MENSCHAERT Gerben Clement Angèle
- Permanent representative, Jan Van den Berghe, mentioned twice in the deed
- Director appointment, NOVALIS (managing director and chair of the board)
- The deed holds 3 more points.
First establishment Foreestelaan 88, Ghent
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 26 November 2018, BioLizard was incorporated.1 In 2019 the registered office moved to Ghent.2 A capital increase in 2020 brought the capital to €466,664.3 Today the board has 2 members.4 Total assets went from €175,463 in 2019 to €5.3m in 2025 and headcount from 2.8 to 34.2 full-time equivalents.5